Top Markets
Coin of the day
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
Clasificación en acciones #24699
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
Precio por acción
$0.95011029
Última sincronización: 2023-06-28
Capitalización bursátil
$57.72M
Cambio (1 día)
8.53%
Cambio (1 año)
0.00%
País
FR
Comercio ERYTECH Pharma S.A. (ERYP)

Categoría

Historial del precio de la acción de ERYTECH Pharma S.A. (ERYP)
Precio más alto de cierre: $0.90 el 2023-06-01

Precio más bajo de cierre: $14.08 el 2013-05-01
Historial del precio de la acción de ERYTECH Pharma S.A. desde 2013 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2023 73.43%
2022 -78.67%
2021 -73.09%
2020 82.31%
2019 -31.19%
2018 -67.04%
2017 59.44%
2016 -51.05%
2015 -15.86%
2014 158.90%
2013 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$549.19 38.17%
US
$1.05K 58.07%
NL
$148.12 464.91%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH